75 related articles for article (PubMed ID: 9125522)
21. A bipartite substrate recognition motif for cyclin-dependent kinases.
Takeda DY; Wohlschlegel JA; Dutta A
J Biol Chem; 2001 Jan; 276(3):1993-7. PubMed ID: 11067844
[TBL] [Abstract][Full Text] [Related]
22. Fluorescent peptide biosensor for probing the relative abundance of cyclin-dependent kinases in living cells.
Kurzawa L; Pellerano M; Coppolani JB; Morris MC
PLoS One; 2011; 6(10):e26555. PubMed ID: 22028905
[TBL] [Abstract][Full Text] [Related]
23. ATP and MO25alpha regulate the conformational state of the STRADalpha pseudokinase and activation of the LKB1 tumour suppressor.
Zeqiraj E; Filippi BM; Goldie S; Navratilova I; Boudeau J; Deak M; Alessi DR; van Aalten DM
PLoS Biol; 2009 Jun; 7(6):e1000126. PubMed ID: 19513107
[TBL] [Abstract][Full Text] [Related]
24. Chemical inhibitors of cyclin-dependent kinases: insights into design from X-ray crystallographic studies.
Noble ME; Endicott JA
Pharmacol Ther; 1999; 82(2-3):269-78. PubMed ID: 10454204
[TBL] [Abstract][Full Text] [Related]
25. Deep insights into the mode of ATP-binding mechanism in Zebrafish cyclin-dependent protein kinase-like 1 (zCDKL1): A molecular dynamics approach.
Rout AK; Dehury B; Maharana J; Nayak C; Baisvar VS; Behera BK; Das BK
J Mol Graph Model; 2018 May; 81():175-183. PubMed ID: 29574323
[TBL] [Abstract][Full Text] [Related]
26. Structural dissection of cyclin dependent kinases regulation and protein recognition properties.
Lolli G
Cell Cycle; 2010 Apr; 9(8):1551-61. PubMed ID: 20372077
[TBL] [Abstract][Full Text] [Related]
27. Identification of an hexapeptide that binds to a surface pocket in cyclin A and inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A.
Canela N; Orzáez M; Fucho R; Mateo F; Gutierrez R; Pineda-Lucena A; Bachs O; Pérez-Payá E
J Biol Chem; 2006 Nov; 281(47):35942-53. PubMed ID: 17001081
[TBL] [Abstract][Full Text] [Related]
28. Orphan kinases turn eccentric: a new class of cyclin Y-activated, membrane-targeted CDKs.
Mikolcevic P; Rainer J; Geley S
Cell Cycle; 2012 Oct; 11(20):3758-68. PubMed ID: 22895054
[TBL] [Abstract][Full Text] [Related]
29. Oxidation of proline from the cyclin-binding motif in maize CDKA;1 results in lower affinity with its cyclin regulatory subunit.
Méndez AAE; Pena LB; Curto LM; Fernández MM; Malchiodi EL; Garza-Aguilar SM; Vázquez-Ramos JM; Gallego SM
Phytochemistry; 2020 Jan; 169():112165. PubMed ID: 31610323
[TBL] [Abstract][Full Text] [Related]
30. Preparation of CDK/Cyclin Inhibitor Complexes for Structural Determination.
Grigoroudis AI; Kontopidis G
Methods Mol Biol; 2016; 1336():29-45. PubMed ID: 26231706
[TBL] [Abstract][Full Text] [Related]
31. Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding.
Faber EB; Sun L; Tang J; Roberts E; Ganeshkumar S; Wang N; Rasmussen D; Majumdar A; Hirsch LE; John K; Yang A; Khalid H; Hawkinson JE; Levinson NM; Chennathukuzhi V; Harki DA; Schönbrunn E; Georg GI
Nat Commun; 2023 Jun; 14(1):3213. PubMed ID: 37270540
[TBL] [Abstract][Full Text] [Related]
32. Molecular principle of the cyclin-dependent kinase selectivity of 4-(thiazol-5-yl)-2-(phenylamino) pyrimidine-5-carbonitrile derivatives revealed by molecular modeling studies.
Kong X; Sun H; Pan P; Tian S; Li D; Li Y; Hou T
Phys Chem Chem Phys; 2016 Jan; 18(3):2034-46. PubMed ID: 26686753
[TBL] [Abstract][Full Text] [Related]
33. Identification of Cyclin A Binders with a Fluorescent Peptide Sensor.
Pazos E; Mascareñas JL; Vázquez ME
Methods Mol Biol; 2016; 1336():67-83. PubMed ID: 26231709
[TBL] [Abstract][Full Text] [Related]
34. Tyr-nitration in maize CDKA;1 results in lower affinity for ATP binding.
Méndez AAE; Mangialavori IC; Cabrera AV; Benavides MP; Vázquez-Ramos JM; Gallego SM
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140479. PubMed ID: 32599297
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of activation in CDK2.
Bešker N; Amadei A; D'Abramo M
J Biomol Struct Dyn; 2014 Dec; 32(12):1929-35. PubMed ID: 24125183
[TBL] [Abstract][Full Text] [Related]
36. Three-dimensional model of the cyclin-dependent kinase 1 (CDK1): Ab initio active site parameters for molecular dynamics studies of CDKS.
Cavalli A; Dezi C; Folkers G; Scapozza L; Recanatini M
Proteins; 2001 Dec; 45(4):478-85. PubMed ID: 11746695
[TBL] [Abstract][Full Text] [Related]
37. Discovery of Pongol, the Furanoflavonoid, as an Inhibitor of CDK7/Cyclin H/MAT1 and Its Preliminary Structure-Activity Relationship.
Bhurta D; Bharate SB
ACS Omega; 2023 Jan; 8(1):1291-1300. PubMed ID: 36643464
[TBL] [Abstract][Full Text] [Related]
38. Emerging approaches to CDK inhibitor development, a structural perspective.
Hope I; Endicott JA; Watt JE
RSC Chem Biol; 2023 Feb; 4(2):146-164. PubMed ID: 36794018
[TBL] [Abstract][Full Text] [Related]
39. Easy Identification of Residues Involved on Structural Differences Between Nonphosphorylated and Phosphorylated CDK2Cyclin A Complexes Using Two-Dimensional Networks.
Riadi G; Caballero J
Mol Inform; 2014 Feb; 33(2):151-62. PubMed ID: 27485571
[TBL] [Abstract][Full Text] [Related]
40. Highlighting the Major Role of Cyclin C in Cyclin-Dependent Kinase 8 Activity through Molecular Dynamics Simulations.
Ziada S; Diharce J; Serillon D; Bonnet P; Aci-Sèche S
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
